Bank of Montreal’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
Other funds holding CYAD
ECM
OMC
Bank of Montreal's CYAD Position: Q2 2021 in Review
Bank of Montreal sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q2 2021, closing a stake of 87 shares — an estimated $1K sold.
Bank of Montreal first reported a position in CYAD in Q4 2017 and held it in 14 quarters. The position peaked at $4K in Q4 2017. 7 funds tracked by Wall St. Rank hold CYAD as of Q2 2021.
- Bank of Montreal reported no remaining Celyad Oncology SA American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Bank of Montreal sold 87 Celyad Oncology SA American Depositary Shares shares in Q2 2021, an estimated $1K.
- Bank of Montreal first reported a position in Celyad Oncology SA American Depositary Shares in Q4 2017 and held it in 14 quarters.
- Bank of Montreal's Celyad Oncology SA American Depositary Shares position peaked at $4K in Q4 2017.
- 7 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2021.
Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.